Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter

Figure 2

'Competition' allocation curves. (a) Predictive probability of patients with more than 10 years of disease duration (DD), those with 2 to 10 years of DD, and those with less than 10 years of DD as a function of the Sharp/van der Heijde (SvdH) score. (b) Predictive probability of patients with more than 10 years of DD and those with less than 10 years of DD as a function of the SvdH score.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us